These non-promotional scientific presentations were presented at the medical congresses referenced below and are intended for U.S healthcare professionals who were in attendance for the purposes of scientific exchange.

These materials may contain information outside of the FDA approved label or relate to uses that have not been approved by the FDA. Syndax does not recommend use of Syndax products in any manner other than as described in the FDA-approved Prescribing Information.

American Society of Clinical Oncology Annual Meeting

Chicago, Illinois May 30 - June 3, 2025

Results 1

Poster Presentation | May 30, 2025

AXALAP: Phase Ib study of AXAtilimab in Combination with OLAParib in BRCA1/2 and PALB2-associated metastatic HER2-negative breast cancer

Lynce F, et al.

View Material